tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Dyne Therapeutics 18.98M share Secondary priced at $18.44

The deal size was increased to $350M from $300M and priced at last closing price of $18.44. Morgan Stanley, Jefferies, Stifel and Guggenheim are acting as joint book running managers for the offering.

Claim 50% Off TipRanks Premium and Invest with Confidence

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1